Episode
Prescription Digital Therapeutics, from Trials to Treatment: Click Therapeutics’ David Benshoof Klein
- Podcast
- from Dreamers to Disruptors
- Published
- Sep 15, 2025
- Duration seconds
- 3477
- Processing state
not_requested- Canonical source
- https://rss.com/podcasts/from-dreamers-to-disruptors/2215794
Actions
POST https://stenobird.com/v1/public/podcasts/from-dreamers-to-disruptors-7329003/episodes/prescription-digital-therapeutics-from-trials-to-treatment-click-therapeutics-david-benshoof-klein/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/from-dreamers-to-disruptors-7329003/prescription-digital-therapeutics-from-trials-to-treatment-click-therapeutics-david-benshoof-klein.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Digital therapeutics are poised to transform healthcare as we know it, delivering Software-Enhanced Drugs™ to patients that extend and expand on traditional treatments, as well as valuable data and new commercial opportunities to pharmaceutical companies. Click Therapeutics is a leading light in prescription digital therapeutics, and CEO David Benshoof Klein’s insights into their design and implementation are second to none. He joins Medidata Solutions’ CEO Anthony Costello to explore the growth of evidence-based, Software-Enhanced Drugs™ and the art of creating effective technologies that change lives. Join David and Anthony to explore the vast potential of digital therapeutics for treating everything from migraines to cancer, and how to build solutions that genuinely benefit patients. They discuss the new Regulatory Considerations for Prescription Drug Use-Related Software (PDURS), and what new legislation means for the growth of software-based treatment adoption around the world. Visit our website Read our blog Follow Medidata: LinkedIn , Instagram , X , YouTube Follow Anthony: LinkedIn Follow David: LinkedIn